BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Apr 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-04-20

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-20	Common Stock	M	5000	$11.05	Acquired	36000	Direct
2011-04-20	Common Stock	S	5000	$27.00	Disposed	31000	Direct
2011-04-20	Common Stock	S	8165	$27.00	Disposed	22835	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-20	Stock Option (right to buy)	$11.05	M	5000	Disposed	2019-03-01	Common Stock (5000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 105-1 Trading plan executed on March 3, 2010.

F2: Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.